Implementing opioid agonist treatment in correctional facilities

K Fiscella, SE Wakeman, L Beletsky - JAMA internal medicine, 2018 - jamanetwork.com
Every year, 1 in 3 of the 2 million people with opioid use disorder in the United States is
arrested. 1 It follows that correctional facilities, that is, detention centers, jails, and prisons …

Abuse-deterrent opioid formulations: part of a public health strategy to reverse the opioid epidemic

HV Kunins - JAMA Internal Medicine, 2015 - jamanetwork.com
Rapid increases in the supply of opioid analgesics have largely driven the nearly
unremitting increase in overdose deaths in the United States, which have grown by more …

Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?

RE Clark, JD Baxter - JAMA Internal Medicine, 2013 - jamanetwork.com
Opioid misuse and addiction has an especially important impact on Medicaid programs;
rates of drug abuse among covered individuals exceed those of other insured populations. 3 …

Trends in buprenorphine use in US jails and prisons from 2016 to 2021

AP Thakrar, GC Alexander, B Saloner - JAMA network open, 2021 - jamanetwork.com
An estimated 15% of the 1.8 million incarcerated individuals in the US have opioid use
disorder (OUD). 1, 2 These individuals have a substantially higher risk of overdose after …

Short-acting opioids for hospitalized patients with opioid use disorder

AP Thakrar - JAMA internal medicine, 2022 - jamanetwork.com
A few months ago, I found one of my patients panhandling on his usual corner. He was in
bad shape. Maggots were crawling through a wound where he regularly injected drugs and …

Facilitating methadone use in hospitals and skilled nursing facilities

JD Pytell, JM Sharfstein, Y Olsen - JAMA internal medicine, 2020 - jamanetwork.com
People with opioid use disorder (OUD) frequently require prolonged hospital and skilled
nursing facility care for complications of their drug use—including wounds, endocarditis …

Challenges of estimating the value of buprenorphine injectables

LS Nelson, J Perrone - JAMA Network Open, 2023 - jamanetwork.com
Opioid overdose is a leading preventable cause of death in the US and has contributed to
the decline in life expectancy. The mortality associated with opioid use disorder continues to …

Opioid use disorder treatment for people involved in the US criminal justice system—promising advances and critical implementation challenges

TNA Winkelman, RS Silva - JAMA network open, 2021 - jamanetwork.com
The US overdose crisis intensified during the COVID-19 pandemic, leading to over 93 000
provisional overdose deaths in 2020. 1 Rising deaths were primarily driven by a steep …

Opioid prescribing trends and the physician's role in responding to the public health crisis

JM Adams, BP Giroir - JAMA Internal Medicine, 2019 - jamanetwork.com
States of opioid overdoses, according to preliminary data from the Centers for Disease
Control and Prevention (CDC). 2 This crisis has spanned different phases, beginning with …

Initiating opioid agonist treatment for opioid use disorder in the inpatient setting: a teachable moment

A Raheemullah, A Lembke - JAMA Internal Medicine, 2019 - jamanetwork.com
Story From the Front Lines A 21-year-old woman with a history of multiple hospital
admissions for sepsis secondary to injection heroin use presented to the hospital with a right …